Evaluation of a fully automatic nucleic acid amplification system for detecting four respiratory pathogens

Area of Science:

• Medical Diagnostics
• Microfluidics
• Molecular Biology

Background:

• Respiratory syncytial virus (RSV), adenovirus (ADV), human parainfluenza virus (hPIV), and Mycoplasma pneumoniae (MP) are common causes of pediatric acute respiratory infections (ARIs).
• Timely and accurate identification of these pathogens is crucial for effective clinical management and differentiation of ARIs in children.
• Current diagnostic methods may have limitations in speed, accuracy, or comprehensiveness for multiple pathogen detection.

Purpose of the Study:

• To evaluate the diagnostic performance of a fully automated real-time fluorescence PCR assay using microfluidic technology (PCR-MT).
• To assess the efficacy of PCR-MT for the rapid, simultaneous detection of RSV, hPIV, ADV, and MP in pediatric patients.
• To compare the diagnostic accuracy of PCR-MT against a established PCR-capillary electrophoresis fragment analysis (PCR-CEFA) method.

Main Methods:

• A cohort of 420 children diagnosed with ARIs was enrolled between March and December 2022.
• Throat swab samples were analyzed using both PCR-MT and PCR-CEFA for the presence of RSV, hPIV, ADV, and MP.
• Results from the PCR-MT method were statistically compared to the gold standard PCR-CEFA.

Main Results:

• The PCR-MT assay demonstrated high sensitivity and specificity across all tested pathogens when compared to PCR-CEFA.
• Specific performance metrics included: RSV (94.4% sensitivity, 100.0% specificity), hPIV (96.0% sensitivity, 99.1% specificity), ADV (100.0% sensitivity, 98.6% specificity), and MP (93.5% sensitivity, 98.8% specificity).
• The assay enabled simultaneous detection of multiple pathogens on a single chip with results available within 30 minutes.

Conclusions:

• The microfluidic-based PCR assay (PCR-MT) shows significant promise for clinical application in diagnosing common respiratory pathogens in children.
• The technology offers a rapid, accurate, and convenient method for early detection and differentiation of RSV, hPIV, ADV, and MP in outpatient settings.
• Continued development and validation of such multi-pathogen detection technologies are essential for improving pediatric respiratory infection diagnostics.